UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathway-specific dopamine abnormalities in schizophrenia

Biological psychiatry (1969), 2017-01, Vol.81 (1), p.31-42

2017

Volltextzugriff (PDF)

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings

Schizophrenia research, 2014-02, Vol.152 (2), p.325-332

2014

Volltextzugriff (PDF)

Detecting schizophrenia with 3D structural brain MRI using deep learning

Scientific reports, 2023-09, Vol.13 (1), p.14433-14433, Article 14433

2023

Volltextzugriff (PDF)

Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers

Neuropsychopharmacology (New York, N.Y.), 2020-10, Vol.45 (11), p.1842-1850

2020

Volltextzugriff (PDF)

Mechanism of action of antipsychotic drugs : From dopamine D2 receptor antagonism to glutamate NMDA facilitation

Clinical therapeutics, 2005, Vol.27, p.S16-S24

2005

Volltextzugriff (PDF)

The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process

American journal of public health (1971), 2001-12, Vol.91 (12), p.1938-1943

2001

Volltextzugriff (PDF)

Neurodegenerative model of schizophrenia: Growing evidence to support a revisit

Schizophrenia research, 2022-05, Vol.243, p.154-162

2022

Volltextzugriff (PDF)

6.94 RELATIONSHIPS BETWEEN SOCIAL AND ROLE FUNCTIONING WITH SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S235-S235

2016

Volltextzugriff (PDF)

Brain GABA Function and Psychosis

The American journal of psychiatry, 2016-05, Vol.173 (5), p.448-449

Kegeles, Lawrence S.

2016

Volltextzugriff (PDF)

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Molecular psychiatry, 2014-01, Vol.19 (1), p.20-29

2014

Volltextzugriff (PDF)

Is schizophrenia neurodevelopmental, neurodegenerative or something else: A reply to Murray et al. (2022)

Schizophrenia research, 2023-11, Vol.261, p.234-235

2023

Volltextzugriff (PDF)

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

Annals of the New York Academy of Sciences, 2003-11, Vol.1003 (1), p.138-158

2003

Volltextzugriff (PDF)

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2018-01, Vol.75 (1), p.11

2018

Volltextzugriff (PDF)

Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine

Biological psychiatry (1969), 2023-07, Vol.94 (2), p.164-173

2023

Volltextzugriff (PDF)

Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients

Neuropsychopharmacology (New York, N.Y.), 2020-07, Vol.45 (8), p.1339-1345

2020

Volltextzugriff (PDF)

Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study

Molecular psychiatry, 2021-06, Vol.26 (6), p.2504-2513

2021

Volltextzugriff (PDF)

Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [ C]McN 5652, [ C]ADAM, [ C]DASB, [ C]DAPA, and [ C]AFM

Journal of cerebral blood flow and metabolism, 2002-11, Vol.22 (11), p.1377-1398

2002

Volltextzugriff (PDF)

Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China

Psychological medicine, 2022-11, Vol.52 (15), p.3655-3667

2022

Volltextzugriff (PDF)

Increased prefrontal cortical D 1 receptors in drug naïve patients with schizophrenia: a PET study with [ 11 C]NNC112

Journal of psychopharmacology (Oxford), 2012-06, Vol.26 (6), p.794-805

2012

Volltextzugriff (PDF)

An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate 1H MRS

Schizophrenia research, 2020-12, Vol.226, p.70-73

2020

Volltextzugriff (PDF)

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

Biological Psychiatry, 1998-09, Vol.44 (6), p.382-398

1998

Volltextzugriff (PDF)

Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder

The journal of clinical psychiatry, 2011-04, Vol.72 (4), p.567-569

2011

Volltextzugriff (PDF)

Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study

European archives of psychiatry and clinical neuroscience, 2020-12, Vol.270 (8), p.1003-1014

2020

Volltextzugriff (PDF)

Long-range gamma phase synchronization as a compensatory strategy during working memory in high-performing patients with schizophrenia

Journal of clinical and experimental neuropsychology, 2018-09, Vol.40 (7), p.663-681

2018

Volltextzugriff (PDF)

(-)-N-[11c]propyl-norapomorphine : A positron-labeled dopamine agonist for PET imaging of D2 receptors

Nuclear medicine and biology, 2000-06, Vol.27 (6), p.533-539

2000

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(342)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(108)
Humans
(73)
Physical Sciences
(44)
Chemistry
(36)
Biological And Medical Sciences
(31)
Psychiatry
(29)
Biochemistry & Molecular Biology
(28)
Social Sciences
(28)
Public, Environmental & Occupational Health
(27)
Schizophrenia
(26)
Neurosciences & Neurology
(24)
Animals
(22)
Medical Sciences
(22)
Neurosciences
(22)
Biophysics
(19)
Mathematics
(19)
Dopamine
(18)
Human Immunodeficiency Virus
(18)
Kinetics
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathway-specific dopamine abnormalities in schizophrenia

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings

Detecting schizophrenia with 3D structural brain MRI using deep learning

Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers

Mechanism of action of antipsychotic drugs : From dopamine D2 receptor antagonism to glutamate NMDA facilitation

The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process

Neurodegenerative model of schizophrenia: Growing evidence to support a revisit

6.94 RELATIONSHIPS BETWEEN SOCIAL AND ROLE FUNCTIONING WITH SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS

Brain GABA Function and Psychosis

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Is schizophrenia neurodevelopmental, neurodegenerative or something else: A reply to Murray et al. (2022)

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine

Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients

Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study

Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [ C]McN 5652, [ C]ADAM, [ C]DASB, [ C]DAPA, and [ C]AFM

Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China

Increased prefrontal cortical D 1 receptors in drug naïve patients with schizophrenia: a PET study with [ 11 C]NNC112

An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate 1H MRS

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder

Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study

Long-range gamma phase synchronization as a compensatory strategy during working memory in high-performing patients with schizophrenia

(-)-N-[11c]propyl-norapomorphine : A positron-labeled dopamine agonist for PET imaging of D2 receptors

Aktive Filter

Suchergebnisse filtern